Campath and renal transplant rejection

Thomas, Philip G
Ishihara, Kanae
Vaidya, Smita
Gugliuzza, Kristene K

^aDepartment of Surgery, The University of Texas Medical Branch, Galveston, TX, USA
^bDepartment of Nephrology, The University of Texas Medical Branch, Galveston, TX, USA
^cDepartment of Pathology, The University of Texas Medical Branch, Galveston, TX, USA

Corresponding author: Philip G. Thomas MD, FACS, Department of Surgery, The University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555, USA. Tel.: (409) 772-0594; fax: (409) 747-7364; e-mail: [email protected]

Accepted for publication 4 August 2004

Clinical Transplantation 18(6):p 759-761, December 2004.

No clear guidelines exist for the treatment of acute vascular rejection following renal transplantation. This report documents one patient who was treated with plasmapheresis, immunoglobulin and Campath with good initial response. However, rejection recurred resulting in graft loss and, in addition, the patient developed post-transplant lymphoma.